MedTrace Logo

Dexlansoprazole MR in Nonerosive Reflux Disease

NCT02490449 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 356

Last updated 2015-07-03

No results posted yet for this study

Summary

This study aim is to compare the efficacy of Dexlansoprazole MR intake before and after breakfast in patients with nonerosive reflux disease.

Conditions

  • Nonerosive Reflux Disease

Interventions

DRUG

Dexlansoprazole MR

Administration of drug after or before diet

Sponsors & Collaborators

  • Soonchunhyang University Hospital

    lead OTHER

Principal Investigators

  • Su Jin Hong · Soonchunhyang University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02490449 on ClinicalTrials.gov